bpc 157 sciatic nerve Peptide therapy with pentadecapeptide in traumatic injury Frontiers | Stable Gastric Pentadecapeptide

Unlike peptides that focus on fat loss or muscle growth, the TB 500 peptide is mainly used for healing and recovery

Cagrilintide is in development as a monotherapy for the treatment of overweight and obesity and as a fixed-dose combination with the glucagon-like peptide-1 receptor agonist, semaglutide (CagriSema) for the treatment of overweight, obesity and type 2 diabetes

PMID 34844587

BPC-157's effects on wound repair involve simultaneous enhancement of multiple healing processes including granulation tissue formation, collagen deposition, and angiogenesis

Bariatric surgery Restricted stomach = reduced B12

The body reabsorbs the remnants